Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2014 1
2015 2
2016 1
2020 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B, Ohyama M, Kwon O, Zlotogorski A, Ko J, Mesinkovska NA, Hordinsky M, Dutronc Y, Wu WS, McCollam J, Chiasserini C, Yu G, Stanley S, Holzwarth K, DeLozier AM, Sinclair R; BRAVE-AA Investigators. King B, et al. N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26. N Engl J Med. 2022. PMID: 35334197 Clinical Trial.
Diversity of KIR/HLA Genotypes and Their Association with Psoriasis Vulgaris in the Western Mexican Population.
Graciano-Machuca O, Alvarado-Navarro A, Ramírez-Dueñas MG, Villanueva-Quintero DG, Velarde-de la Cruz EE, Machado-Sulbarán AC, Montoya-Buelna M, Sánchez-Hernández PE. Graciano-Machuca O, et al. Among authors: villanueva quintero dg. Genes (Basel). 2020 Mar 22;11(3):338. doi: 10.3390/genes11030338. Genes (Basel). 2020. PMID: 32235781 Free PMC article.
Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data.
Papp KA, Gooderham M, Dei-Cas I, LopezTello A, Garcia-Rodriguez JC, Taveras CY, Rousselin AH, Lavieri A, Maiolino M, Quintero DGV, Rihakova L, Salibe M, Pertuz W. Papp KA, et al. Among authors: quintero dgv. Dermatol Ther (Heidelb). 2023 Jan;13(1):269-283. doi: 10.1007/s13555-022-00849-0. Epub 2022 Dec 10. Dermatol Ther (Heidelb). 2023. PMID: 36496547 Free PMC article.
[Dermoscopic pattern in tinea capitis].
Sandoval AB, Ortiz JA, Rodríguez JM, Vargas AG, Quintero DG. Sandoval AB, et al. Among authors: quintero dg. Rev Iberoam Micol. 2010 Sep 30;27(3):151-2. doi: 10.1016/j.riam.2010.02.003. Epub 2010 Mar 24. Rev Iberoam Micol. 2010. PMID: 20346297 Spanish. No abstract available.
Macrophage migration inhibitory factor gene polymorphisms (SNP -173 G>C and STR-794 CATT5-8) confer risk of plaque psoriasis: A case-control study.
Hernández-Bello J, Rodríguez-Puente M, Gutiérrez-Cuevas J, García-Arellano S, Muñoz-Valle JF, Fafutis-Morris M, Villanueva-Quintero DG, Alvarado-Navarro A. Hernández-Bello J, et al. Among authors: villanueva quintero dg. J Clin Lab Anal. 2021 Nov;35(11):e23999. doi: 10.1002/jcla.23999. Epub 2021 Sep 17. J Clin Lab Anal. 2021. PMID: 34533238 Free PMC article.
Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials.
Papp KA, Menter MA, Abe M, Elewski B, Feldman SR, Gottlieb AB, Langley R, Luger T, Thaci D, Buonanno M, Gupta P, Proulx J, Lan S, Wolk R; OPT Pivotal 1 and OPT Pivotal 2 investigators. Papp KA, et al. Br J Dermatol. 2015 Oct;173(4):949-61. doi: 10.1111/bjd.14018. Br J Dermatol. 2015. PMID: 26149717 Clinical Trial.
The 3'UTR 1188A/C polymorphism of IL-12p40 is not associated with susceptibility for developing plaque psoriasis in Mestizo population from western Mexico.
Sandoval-Talamantes AK, Brito-Luna MJ, Fafutis-Morris M, Villanueva-Quintero DG, Graciano-Machuca O, Ramírez-Dueñas MG, Alvarado-Navarro A. Sandoval-Talamantes AK, et al. Among authors: villanueva quintero dg. Immunol Lett. 2015 Feb;163(2):221-6. doi: 10.1016/j.imlet.2014.10.004. Epub 2014 Oct 17. Immunol Lett. 2015. PMID: 25447399